Abrdn Life Sciences Investors (HQL) Short Interest Ratio & Short Volume $12.16 -0.39 (-3.07%) Closing price 05/22/2025 03:58 PM EasternExtended Trading$12.16 0.00 (-0.04%) As of 05/22/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Abrdn Life Sciences Investors Short Interest DataAbrdn Life Sciences Investors (HQL) has a short interest of 24,200 shares. This marks a -78.35% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 104,923 shares to cover all short positions.Current Short Interest24,200 sharesPrevious Short Interest111,800 sharesChange Vs. Previous Month-78.35%Dollar Volume Sold Short$310,244.00Short Interest Ratio0.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares28,872,000 sharesPercentage of Shares Shorted0.08%Today's Trading Volume164,946 sharesAverage Trading Volume104,923 sharesToday's Volume Vs. Average157% Short Selling Abrdn Life Sciences Investors? Sign up to receive the latest short interest report for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHQL Short Interest Over TimeHQL Days to Cover Over TimeHQL Percentage of Float Shorted Over Time Abrdn Life Sciences Investors Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202524,200 shares $310,244.00 -78.4%N/A0.2 $12.82 4/15/2025111,800 shares $1.32 million +46.5%0.5%0.8 $11.81 3/31/202576,300 shares $966,721.00 +26.3%0.3%0.6 $12.67 3/15/202560,400 shares $781,878.00 -37.4%0.2%0.4 $12.95 2/28/202596,500 shares $1.30 million +94.6%0.4%0.7 $13.45 2/15/202549,600 shares $694,896.00 +100.8%0.2%0.4 $14.01 1/31/202524,700 shares $351,481.00 -46.0%N/A0.2 $14.23 1/15/202545,700 shares $616,036.00 -41.3%N/A0.4 $13.48 12/31/202477,800 shares $1.02 million +212.5%N/A0.8 $13.12 12/15/202424,900 shares $344,616.00 -26.3%N/A0.3 $13.84 Get the Latest News and Ratings for HQL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. 11/30/202433,800 shares $481,988.00 -54.4%N/A0.4 $14.26 11/15/202474,100 shares $1.02 million +17.3%N/A1 $13.72 10/31/202463,200 shares $920,192.00 +1.4%N/A1 $14.56 10/15/202462,300 shares $931,385.00 -58.9%N/A0.9 $14.95 9/30/2024151,500 shares $2.28 million -1.7%N/A1.6 $15.07 9/15/2024154,100 shares $2.35 million -10.8%N/A1.6 $15.28 8/31/2024172,800 shares $2.61 million -22.0%N/A1.9 $15.13 8/15/2024221,500 shares $3.42 million -16.1%N/A2.4 $15.44 7/31/2024264,100 shares $4.06 million +4,978.9%N/A2.7 $15.37 7/15/20245,200 shares $79,456.00 -67.7%N/A0.1 $15.28 6/30/202416,100 shares $228,137.00 +67.7%N/A0.2 $14.17 6/15/20249,600 shares $132,671.04 -72.4%N/A0.1 $13.82 5/31/202434,800 shares $463,536.00 -52.7%N/A0.4 $13.32 5/15/202473,600 shares $1.05 million +26.0%N/A0.9 $14.27 4/30/202458,400 shares $765,624.00 +205.8%N/A0.6 $13.11 4/15/202419,100 shares $247,918.00 -10.3%N/A0.2 $12.98 3/31/202421,300 shares $290,319.00 -27.6%N/A0.2 $13.63 3/15/202429,400 shares $396,900.00 -47.5%N/A0.2 $13.50 2/29/202456,000 shares $767,200.00 -58.0%N/A0.4 $13.70 2/15/2024133,400 shares $1.87 million +895.5%N/A1 $14.05 1/31/202413,400 shares $183,848.00 -86.2%N/A0.1 $13.72 1/15/202496,900 shares $1.37 million +37.1%N/A0.8 $14.16 12/31/202370,700 shares $951,622.00 +30.2%N/A0.5 $13.46 12/15/202354,300 shares $714,045.00 +18.0%N/A0.4 $13.15 11/30/202346,000 shares $549,240.00 -51.0%N/A0.4 $11.94 11/15/202393,800 shares $1.13 million +186.0%N/A0.8 $12.04 10/31/202332,800 shares $380,152.00 -42.9%N/A0.3 $11.59 10/15/202357,400 shares $704,872.00 +71.9%N/A0.5 $12.28 9/30/202333,400 shares $416,498.00 -7.2%N/A0.3 $12.47 9/15/202336,000 shares $461,880.00 +40.1%N/A0.4 $12.83Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/31/202325,700 shares $334,357.00 +71.3%N/A0.3 $13.01 8/15/202315,000 shares $201,300.00 -63.0%N/A0.2 $13.42 7/31/202340,500 shares $544,725.00 +282.1%N/A0.4 $13.45 7/15/202310,600 shares $142,146.00 -85.7%N/A0.1 $13.41 6/30/202374,000 shares $1.00 million +695.7%N/A1 $13.55 6/15/20239,300 shares $128,712.00 No ChangeN/A0.1 $13.84 5/31/20239,300 shares $123,597.00 -76.6%N/A0.1 $13.29 5/15/202339,800 shares $559,588.00 -27.2%N/A0.5 $14.06 4/30/202354,700 shares $761,971.00 -2.0%N/A0.7 $13.93 4/15/202355,800 shares $782,874.00 -1.8%N/A0.7 $14.03 3/31/202356,800 shares $791,224.00 -45.8%N/A0.7 $13.93 3/15/2023104,700 shares $1.44 million +408.3%N/A1 $13.72 2/28/202320,600 shares $287,576.00 +186.1%N/A0.2 $13.96 2/15/20237,200 shares $105,336.00 -22.6%N/A0.1 $14.63 1/31/20239,300 shares $138,942.00 -17.7%N/A0.1 $14.94 1/15/202311,300 shares $166,788.00 -50.9%N/A0.1 $14.76 12/30/202223,000 shares $326,830.00 +62.0%N/A0.2 $14.21 12/15/202214,200 shares $209,024.00 -10.7%N/A0.1 $14.72 11/30/202215,900 shares $239,772.00 +28.2%N/A0.2 $15.08 11/15/202212,400 shares $186,620.00 +7.8%N/A0.1 $15.05 10/31/202211,500 shares $168,475.00 -62.9%N/A0.1 $14.65 10/15/202231,000 shares $427,490.00 No ChangeN/A0.4 $13.79 9/30/202224,000 shares $327,840.00 -33.9%N/A0.3 $13.66 9/15/202236,300 shares $537,240.00 +80.6%N/A0.5 $14.80 8/31/202220,100 shares $290,244.00 +55.8%N/A0.3 $14.44 8/15/202212,900 shares $210,399.00 +79.2%N/A0.2 $16.31 7/31/20227,200 shares $107,424.00 -77.1%N/A0.1 $14.92 7/15/202231,400 shares $475,082.00 +91.5%N/A0.4 $15.13 6/30/202216,400 shares $233,372.00 +11.6%N/A0.2 $14.23 6/15/202214,700 shares $198,156.00 +110.0%N/A0.2 $13.48 5/31/20227,000 shares $101,990.00 -84.6%N/A0.1 $14.57 5/15/202245,400 shares $653,760.00 -30.5%N/A0.6 $14.40 4/30/202265,300 shares $1.01 million +262.8%N/A0.9 $15.49 4/15/202218,000 shares $303,660.00 -1.1%N/A0.2 $16.87 3/31/202218,200 shares $301,028.00 -55.6%N/A0.2 $16.54 3/15/202241,000 shares $637,550.00 -67.6%N/A0.4 $15.55 2/28/2022126,600 shares $2.09 million -36.0%N/A1.4 $16.47 2/15/2022197,700 shares $3.48 million -18.6%N/A2.1 $17.61 1/31/2022243,000 shares $4.41 million +130.6%N/A2.8 $18.15 1/15/2022105,400 shares $1.96 million +626.9%N/A1.2 $18.56 12/31/202114,500 shares $278,835.00 -85.8%N/A0.2 $19.23 12/15/2021102,200 shares $1.95 million -5.0%N/A1.5 $19.10 11/30/2021107,600 shares $2.13 million -29.9%N/A1.7 $19.84 11/15/2021153,400 shares $3.15 million -0.5%N/A2.5 $20.54 10/29/2021154,100 shares $3.28 million +553.0%N/A2.2 $21.27 10/15/202123,600 shares $487,576.00 +34.9%N/A0.3 $20.66 9/30/202117,500 shares $364,000.00 -61.8%N/A0.3 $20.80 9/15/202145,800 shares $996,608.00 +70.3%N/A0.7 $21.76 8/31/202126,900 shares $587,765.00 -40.5%N/A0.4 $21.85 8/13/202145,200 shares $980,840.00 +396.7%N/A0.6 $21.70Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 7/30/20219,100 shares $189,280.00 +37.9%N/A0.1 $20.80 7/15/20216,600 shares $135,894.00 -85.5%N/A0.1 $20.59 6/30/202145,500 shares $975,520.00 +792.2%N/A0.6 $21.44 6/15/20215,100 shares $106,335.00 -88.5%N/A0.1 $20.85 5/28/202144,400 shares $884,892.00 -5.7%N/A0.5 $19.93 5/14/202147,100 shares $901,494.00 -12.9%N/A0.5 $19.14 4/30/202154,100 shares $1.10 million +12.0%N/A0.6 $20.34 4/15/202148,300 shares $951,993.00 -60.5%N/A0.6 $19.71 3/31/2021122,300 shares $2.39 million +38.7%N/A1.4 $19.51 3/15/202188,200 shares $1.78 million -23.8%N/A1.1 $20.23 2/26/2021115,700 shares $2.43 million +105.9%N/A1.4 $21.00 2/12/202156,200 shares $1.23 million +561.2%N/A0.7 $21.85 1/29/20218,500 shares $171,785.00 -76.7%N/A0.1 $20.21 1/15/202136,400 shares $744,016.00 -25.3%N/A0.5 $20.44 12/31/202048,700 shares $963,773.00 +549.3%N/A0.6 $19.79 12/15/20207,500 shares $145,200.00 -86.4%N/A0.1 $19.36 11/30/202055,000 shares $1.03 million +63.7%N/A0.7 $18.73 11/15/202033,600 shares $612,864.00 -19.2%N/A0.4 $18.24 10/30/202041,600 shares $715,104.00 +222.5%N/A0.5 $17.19 10/15/202012,900 shares $236,844.00 -18.4%N/A0 $18.36 9/30/202015,800 shares $277,764.00 -81.4%N/A0.2 $17.58 9/15/202011,000 shares $196,350.00 -87.1%N/A0.1 $17.85 8/31/202085,000 shares $1.52 million +135.5%N/A1 $17.83 8/14/202036,100 shares $646,190.00 -37.4%N/A0.4 $17.90 7/31/202057,700 shares $1.03 million +262.9%N/A0.6 $17.91 7/15/202015,900 shares $293,832.00 +40.7%N/A0.2 $18.48 6/30/202011,300 shares $199,332.00 -65.7%N/A0.1 $17.64 6/15/202032,900 shares $567,854.00 -9.6%N/A0.3 $17.26 5/29/202036,400 shares $642,460.00 +318.4%N/A0.3 $17.65 HQL Short Interest - Frequently Asked Questions What is Abrdn Life Sciences Investors' current short interest? Short interest is the volume of Abrdn Life Sciences Investors shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 24,200 shares of HQL short. Learn More on Abrdn Life Sciences Investors' current short interest. Is Abrdn Life Sciences Investors' short interest increasing or decreasing? Abrdn Life Sciences Investors saw a decrease in short interest in April. As of April 30th, there was short interest totaling 24,200 shares, a decrease of 78.4% from the previous total of 111,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Abrdn Life Sciences Investors' short interest compare to its competitors? Here is how the short interest of companies in the industry of "financial services" compare to Abrdn Life Sciences Investors: Goldman Sachs BDC, Inc. (2.00%), MidCap Financial Investment Co. (0.81%), New Mountain Finance Co. (1.87%), BlackRock MuniHoldings California Quality Fund, Inc. (0.10%), Bain Capital Specialty Finance, Inc. (0.43%), AllianceBernstein Global High Income Fund (0.12%), Barings BDC, Inc. (0.58%), Abrdn Healthcare Investors (0.07%), PIMCO High Income Fund (0.13%), Carlyle Secured Lending, Inc. (0.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Abrdn Life Sciences Investors stock? Short selling HQL is an investing strategy that aims to generate trading profit from Abrdn Life Sciences Investors as its price is falling. HQL shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abrdn Life Sciences Investors? A short squeeze for Abrdn Life Sciences Investors occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HQL, which in turn drives the price of the stock up even further. How often is Abrdn Life Sciences Investors' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HQL, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Goldman Sachs BDC Short Interest Data MidCap Financial Investment Short Interest Data New Mountain Finance Short Interest Data BlackRock MuniHoldings California Quality Fund Short Interest Data Bain Capital Specialty Finance Short Interest Data AllianceBernstein Global High Income Fund Short Interest Data Barings BDC Short Interest Data Abrdn Healthcare Investors Short Interest Data PIMCO High Income Fund Short Interest Data Carlyle Secured Lending Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:HQL) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HQL Stock Free HQL Stock Alerts